Global Iodine-containing Contrast Medium Market Growth 2023-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,660	114 Pages	LP Information, Inc.	January, 2023	LPI17670955

Best Price Guarantee
Price	from $3,660
Length	114 Pages
Publisher	LP Information, Inc.
Published Date	January, 2023
SKU	LPI17670955

Global Iodine-containing Contrast Medium Market Growth 2023-2029

LPI (LP Information)' newest research report, the “Iodine-containing Contrast Medium Industry Forecast” looks at past sales and reviews total world Iodine-containing Contrast Medium sales in 2022, providing a comprehensive analysis by region and market sector of projected Iodine-containing Contrast Medium sales for 2023 through 2029. With Iodine-containing Contrast Medium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Iodine-containing Contrast Medium industry.

This Insight Report provides a comprehensive analysis of the global Iodine-containing Contrast Medium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Iodine-containing Contrast Medium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Iodine-containing Contrast Medium market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Iodine-containing Contrast Medium and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Iodine-containing Contrast Medium.

The global Iodine-containing Contrast Medium market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Iodine-containing Contrast Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Iodine-containing Contrast Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Iodine-containing Contrast Medium is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Iodine-containing Contrast Medium players cover GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, Hengrui Medicine, Lantheus, Sanochemia, Tyco Healthcare and Imax, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Iodine-containing Contrast Medium market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Iohexol
Iodixanol
Iopamidol
Ioversol
Others

Segmentation by application
Hospitals
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
Sanochemia
Tyco Healthcare
Imax
Takeda
Fuji Pharma
Towaseiyaku
Hikari Pharmaceutical
Consentis Diagnostics GmbH
T2Pharma
YRPG
BeiLu Pharma
Grupo Juste
Daiichi Sankyo

Key Questions Addressed in this Report

What is the 10-year outlook for the global Iodine-containing Contrast Medium market?

What factors are driving Iodine-containing Contrast Medium market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Iodine-containing Contrast Medium market opportunities vary by end market size?

How does Iodine-containing Contrast Medium break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.

*This is a tentative TOC and the final deliverable is subject to change.*

1 Scope of the Report: 1.1 Market Introduction; 1.2 Years Considered; 1.3 Research Objectives; 1.4 Market Research Methodology; 1.5 Research Process and Data Source; 1.6 Economic Indicators; 1.7 Currency Considered; 1.8 Market Estimation Caveats
2 Executive Summary: 2.1 World Market Overview; 2.1.1 Global Iodine-containing Contrast Medium Annual Sales 2018-2029; 2.1.2 World Current & Future Analysis for Iodine-containing Contrast Medium by Geographic Region, 2018, 2022 & 2029; 2.1.3 World Current & Future Analysis for Iodine-containing Contrast Medium by Country/Region, 2018, 2022 & 2029; 2.2 Iodine-containing Contrast Medium Segment by Type; 2.2.1 Iohexol; 2.2.2 Iodixanol; 2.2.3 Iopamidol; 2.2.4 Ioversol; 2.2.5 Others; 2.3 Iodine-containing Contrast Medium Sales by Type; 2.3.1 Global Iodine-containing Contrast Medium Sales Market Share by Type (2018-2023); 2.3.2 Global Iodine-containing Contrast Medium Revenue and Market Share by Type (2018-2023); 2.3.3 Global Iodine-containing Contrast Medium Sale Price by Type (2018-2023); 2.4 Iodine-containing Contrast Medium Segment by Application; 2.4.1 Hospitals; 2.4.2 Clinics; 2.4.3 Others; 2.5 Iodine-containing Contrast Medium Sales by Application; 2.5.1 Global Iodine-containing Contrast Medium Sale Market Share by Application (2018-2023); 2.5.2 Global Iodine-containing Contrast Medium Revenue and Market Share by Application (2018-2023); 2.5.3 Global Iodine-containing Contrast Medium Sale Price by Application (2018-2023)
3 Global Iodine-containing Contrast Medium by Company: 3.1 Global Iodine-containing Contrast Medium Breakdown Data by Company; 3.1.1 Global Iodine-containing Contrast Medium Annual Sales by Company (2018-2023); 3.1.2 Global Iodine-containing Contrast Medium Sales Market Share by Company (2018-2023); 3.2 Global Iodine-containing Contrast Medium Annual Revenue by Company (2018-2023); 3.2.1 Global Iodine-containing Contrast Medium Revenue by Company (2018-2023); 3.2.2 Global Iodine-containing Contrast Medium Revenue Market Share by Company (2018-2023); 3.3 Global Iodine-containing Contrast Medium Sale Price by Company; 3.4 Key Manufacturers Iodine-containing Contrast Medium Producing Area Distribution, Sales Area, Product Type; 3.4.1 Key Manufacturers Iodine-containing Contrast Medium Product Location Distribution; 3.4.2 Players Iodine-containing Contrast Medium Products Offered; 3.5 Market Concentration Rate Analysis; 3.5.1 Competition Landscape Analysis; 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023); 3.6 New Products and Potential Entrants; 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Iodine-containing Contrast Medium by Geographic Region: 4.1 World Historic Iodine-containing Contrast Medium Market Size by Geographic Region (2018-2023); 4.1.1 Global Iodine-containing Contrast Medium Annual Sales by Geographic Region (2018-2023); 4.1.2 Global Iodine-containing Contrast Medium Annual Revenue by Geographic Region (2018-2023); 4.2 World Historic Iodine-containing Contrast Medium Market Size by Country/Region (2018-2023); 4.2.1 Global Iodine-containing Contrast Medium Annual Sales by Country/Region (2018-2023); 4.2.2 Global Iodine-containing Contrast Medium Annual Revenue by Country/Region (2018-2023); 4.3 Americas Iodine-containing Contrast Medium Sales Growth; 4.4 APAC Iodine-containing Contrast Medium Sales Growth; 4.5 Europe Iodine-containing Contrast Medium Sales Growth; 4.6 Middle East & Africa Iodine-containing Contrast Medium Sales Growth
5 Americas: 5.1 Americas Iodine-containing Contrast Medium Sales by Country; 5.1.1 Americas Iodine-containing Contrast Medium Sales by Country (2018-2023); 5.1.2 Americas Iodine-containing Contrast Medium Revenue by Country (2018-2023); 5.2 Americas Iodine-containing Contrast Medium Sales by Type; 5.3 Americas Iodine-containing Contrast Medium Sales by Application; 5.4 United States; 5.5 Canada; 5.6 Mexico; 5.7 Brazil
6 APAC: 6.1 APAC Iodine-containing Contrast Medium Sales by Region; 6.1.1 APAC Iodine-containing Contrast Medium Sales by Region (2018-2023); 6.1.2 APAC Iodine-containing Contrast Medium Revenue by Region (2018-2023); 6.2 APAC Iodine-containing Contrast Medium Sales by Type; 6.3 APAC Iodine-containing Contrast Medium Sales by Application; 6.4 China; 6.5 Japan; 6.6 South Korea; 6.7 Southeast Asia; 6.8 India; 6.9 Australia; 6.10 China Taiwan
7 Europe: 7.1 Europe Iodine-containing Contrast Medium by Country; 7.1.1 Europe Iodine-containing Contrast Medium Sales by Country (2018-2023); 7.1.2 Europe Iodine-containing Contrast Medium Revenue by Country (2018-2023); 7.2 Europe Iodine-containing Contrast Medium Sales by Type; 7.3 Europe Iodine-containing Contrast Medium Sales by Application; 7.4 Germany; 7.5 France; 7.6 UK; 7.7 Italy; 7.8 Russia
8 Middle East & Africa: 8.1 Middle East & Africa Iodine-containing Contrast Medium by Country; 8.1.1 Middle East & Africa Iodine-containing Contrast Medium Sales by Country (2018-2023); 8.1.2 Middle East & Africa Iodine-containing Contrast Medium Revenue by Country (2018-2023); 8.2 Middle East & Africa Iodine-containing Contrast Medium Sales by Type; 8.3 Middle East & Africa Iodine-containing Contrast Medium Sales by Application; 8.4 Egypt; 8.5 South Africa; 8.6 Israel; 8.7 Turkey; 8.8 GCC Countries
9 Market Drivers, Challenges and Trends: 9.1 Market Drivers & Growth Opportunities; 9.2 Market Challenges & Risks; 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis: 10.1 Raw Material and Suppliers; 10.2 Manufacturing Cost Structure Analysis of Iodine-containing Contrast Medium; 10.3 Manufacturing Process Analysis of Iodine-containing Contrast Medium; 10.4 Industry Chain Structure of Iodine-containing Contrast Medium
11 Marketing, Distributors and Customer: 11.1 Sales Channel; 11.1.1 Direct Channels; 11.1.2 Indirect Channels; 11.2 Iodine-containing Contrast Medium Distributors; 11.3 Iodine-containing Contrast Medium Customer
12 World Forecast Review for Iodine-containing Contrast Medium by Geographic Region: 12.1 Global Iodine-containing Contrast Medium Market Size Forecast by Region; 12.1.1 Global Iodine-containing Contrast Medium Forecast by Region (2024-2029); 12.1.2 Global Iodine-containing Contrast Medium Annual Revenue Forecast by Region (2024-2029); 12.2 Americas Forecast by Country; 12.3 APAC Forecast by Region; 12.4 Europe Forecast by Country; 12.5 Middle East & Africa Forecast by Country; 12.6 Global Iodine-containing Contrast Medium Forecast by Type; 12.7 Global Iodine-containing Contrast Medium Forecast by Application
13 Key Players Analysis: 13.1 GE Healthcare; 13.1.1 GE Healthcare Company Information; 13.1.2 GE Healthcare Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.1.3 GE Healthcare Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.1.4 GE Healthcare Main Business Overview; 13.1.5 GE Healthcare Latest Developments; 13.2 Bayer; 13.2.1 Bayer Company Information; 13.2.2 Bayer Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.2.3 Bayer Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.2.4 Bayer Main Business Overview; 13.2.5 Bayer Latest Developments; 13.3 Bracco Imaging; 13.3.1 Bracco Imaging Company Information; 13.3.2 Bracco Imaging Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.3.3 Bracco Imaging Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.3.4 Bracco Imaging Main Business Overview; 13.3.5 Bracco Imaging Latest Developments; 13.4 Guerbet Group; 13.4.1 Guerbet Group Company Information; 13.4.2 Guerbet Group Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.4.3 Guerbet Group Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.4.4 Guerbet Group Main Business Overview; 13.4.5 Guerbet Group Latest Developments; 13.5 Hengrui Medicine; 13.5.1 Hengrui Medicine Company Information; 13.5.2 Hengrui Medicine Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.5.3 Hengrui Medicine Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.5.4 Hengrui Medicine Main Business Overview; 13.5.5 Hengrui Medicine Latest Developments; 13.6 Lantheus; 13.6.1 Lantheus Company Information; 13.6.2 Lantheus Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.6.3 Lantheus Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.6.4 Lantheus Main Business Overview; 13.6.5 Lantheus Latest Developments; 13.7 Sanochemia; 13.7.1 Sanochemia Company Information; 13.7.2 Sanochemia Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.7.3 Sanochemia Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.7.4 Sanochemia Main Business Overview; 13.7.5 Sanochemia Latest Developments; 13.8 Tyco Healthcare; 13.8.1 Tyco Healthcare Company Information; 13.8.2 Tyco Healthcare Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.8.3 Tyco Healthcare Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.8.4 Tyco Healthcare Main Business Overview; 13.8.5 Tyco Healthcare Latest Developments; 13.9 Imax; 13.9.1 Imax Company Information; 13.9.2 Imax Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.9.3 Imax Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.9.4 Imax Main Business Overview; 13.9.5 Imax Latest Developments; 13.10 Takeda; 13.10.1 Takeda Company Information; 13.10.2 Takeda Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.10.3 Takeda Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.10.4 Takeda Main Business Overview; 13.10.5 Takeda Latest Developments; 13.11 Fuji Pharma; 13.11.1 Fuji Pharma Company Information; 13.11.2 Fuji Pharma Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.11.3 Fuji Pharma Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.11.4 Fuji Pharma Main Business Overview; 13.11.5 Fuji Pharma Latest Developments; 13.12 Towaseiyaku; 13.12.1 Towaseiyaku Company Information; 13.12.2 Towaseiyaku Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.12.3 Towaseiyaku Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.12.4 Towaseiyaku Main Business Overview; 13.12.5 Towaseiyaku Latest Developments; 13.13 Hikari Pharmaceutical; 13.13.1 Hikari Pharmaceutical Company Information; 13.13.2 Hikari Pharmaceutical Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.13.3 Hikari Pharmaceutical Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.13.4 Hikari Pharmaceutical Main Business Overview; 13.13.5 Hikari Pharmaceutical Latest Developments; 13.14 Consentis Diagnostics GmbH; 13.14.1 Consentis Diagnostics GmbH Company Information; 13.14.2 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.14.3 Consentis Diagnostics GmbH Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.14.4 Consentis Diagnostics GmbH Main Business Overview; 13.14.5 Consentis Diagnostics GmbH Latest Developments; 13.15 T2Pharma; 13.15.1 T2Pharma Company Information; 13.15.2 T2Pharma Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.15.3 T2Pharma Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.15.4 T2Pharma Main Business Overview; 13.15.5 T2Pharma Latest Developments; 13.16 YRPG; 13.16.1 YRPG Company Information; 13.16.2 YRPG Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.16.3 YRPG Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.16.4 YRPG Main Business Overview; 13.16.5 YRPG Latest Developments; 13.17 BeiLu Pharma; 13.17.1 BeiLu Pharma Company Information; 13.17.2 BeiLu Pharma Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.17.3 BeiLu Pharma Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.17.4 BeiLu Pharma Main Business Overview; 13.17.5 BeiLu Pharma Latest Developments; 13.18 Grupo Juste; 13.18.1 Grupo Juste Company Information; 13.18.2 Grupo Juste Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.18.3 Grupo Juste Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.18.4 Grupo Juste Main Business Overview; 13.18.5 Grupo Juste Latest Developments; 13.19 Daiichi Sankyo; 13.19.1 Daiichi Sankyo Company Information; 13.19.2 Daiichi Sankyo Iodine-containing Contrast Medium Product Portfolios and Specifications; 13.19.3 Daiichi Sankyo Iodine-containing Contrast Medium Sales, Revenue, Price and Gross Margin (2018-2023); 13.19.4 Daiichi Sankyo Main Business Overview; 13.19.5 Daiichi Sankyo Latest Developments
14 Research Findings and Conclusion